anygen
-
HLB Group Acquires ANYGEN to Expand Peptide-Based TherapeuticsBig Tech 2025. 3. 11. 02:22
· Strategic acquisition secures key GMP-certified manufacturing, fuels GLP-1 innovation and oncology advancements. SEOUL, South Korea, March 10, 2025 (IT Times) – HLB Group has announced its acquisition of ANYGEN, a South Korean biotechnology company boasting the nation's only GMP-certified peptide manufacturing facility. This strategic move positions HLB Group to capitalize on the burgeoning ma..